Revvity (NYSE:RVTY) Shares Up 5.2% – Time to Buy?

Shares of Revvity Inc. (NYSE:RVTY) were up 5.2% on Thursday . The company traded as high as $148.53 and last traded at $149.4930. Approximately 1,039,798 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 1,467,490 shares. The stock had previously closed at $142.11.

More Revvity News

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: New diabetes-testing solution: Revvity launched an IVDR-certified solution designed to help detect Type 1 diabetes at an early stage. The certification may improve the product’s commercial prospects in Europe and strengthen Revvity’s position in diagnostic testing. Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
• Positive Sentiment: Recent operating momentum: Revvity’s latest reported quarter exceeded analyst expectations for both earnings and revenue, while its full-year 2026 EPS guidance remains $5.30-$5.40. The diabetes launch gives investors an additional potential growth catalyst as the company works to offset modest year-over-year revenue pressure. Top Midday Stories: Revvity’s New Diabetes Test
• Neutral Sentiment: Analyst stance remains cautious: Goldman Sachs maintained a Hold rating, consistent with the broader consensus Hold view. Several firms have assigned price targets below the stock’s recent trading range, suggesting investors may already be pricing in considerable improvement. Goldman Sachs Remains a Hold on Revvity
• Negative Sentiment: Insider selling: Insider Maxwell Krakowiak sold 1,631 shares for approximately $235,728, reducing his direct ownership by nearly 10%. The transaction is relatively small compared with Revvity’s market value, but it may add modest selling pressure or investor caution after the stock’s strong run. Revvity Insider Sells 1,631 Shares

Analysts Set New Price Targets

RVTY has been the subject of several recent analyst reports. Royal Bank Of Canada assumed coverage on shares of Revvity in a research note on Tuesday, September 1st. They issued a “sector perform” rating and a $135.00 target price for the company. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. KeyCorp increased their price objective on shares of Revvity from $125.00 to $165.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Finally, Evercore reiterated an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $116.57.

Revvity Trading Up 6.5%

The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The stock has a market capitalization of $16.88 billion, a PE ratio of 71.90, a PEG ratio of 2.61 and a beta of 1.09. The stock’s 50 day simple moving average is $122.53 and its two-hundred day simple moving average is $105.76.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same quarter in the previous year, the firm posted $1.18 EPS. Revvity’s revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts expect that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Insider Activity at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the sale, the insider owned 6,635 shares in the company, valued at $934,738.80. This represents a 52.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the transaction, the insider directly owned 14,781 shares of the company’s stock, valued at $2,136,297.93. The trade was a 9.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 9,046 shares of company stock worth $1,277,685. Insiders own 0.85% of the company’s stock.

Institutional Trading of Revvity

A number of institutional investors have recently added to or reduced their stakes in RVTY. Public Employees Retirement System of Ohio bought a new position in shares of Revvity in the second quarter valued at approximately $3,845,000. Bank of New York Mellon Corp bought a new position in Revvity in the 2nd quarter valued at $78,766,000. Tocqueville Asset Management L.P. purchased a new position in shares of Revvity during the 2nd quarter valued at $4,791,000. California State Teachers Retirement System increased its holdings in shares of Revvity by 19.8% in the first quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after purchasing an additional 22,075 shares during the period. Finally, The Manufacturers Life Insurance Company raised its position in shares of Revvity by 5.8% in the second quarter. The Manufacturers Life Insurance Company now owns 368,938 shares of the company’s stock worth $41,048,000 after buying an additional 20,278 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.